Skip to main content
. 2019 Mar 7;14(3):e0213096. doi: 10.1371/journal.pone.0213096

Table 4. Median RAS peptide concentrations and ratios between ARDS patients grouped by their renal failure status at study entry.

RAS peptide/ Ratio Median concentration or ratio (interquartile range)
No Renal Failure (N = 17) Renal Failure (n = 22) p-value
A(1–5) 0.05 (0.05–0.14) 0.44 (0.09–0.73) 0.003
A(1–9) 1.88 (0.63–3.50) 0.69 (0.05–1.83) 0.025
A(1–5)/ A(1–7) 0.18 (0.12–1.25) 1.00 (0.46–3.11) 0.02
A(1–9)/ A(1–10) 0.64 (0.14–2.06) 0.10 (0.05–0.52) 0.023